BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 25510918)

  • 1. The diverse oncogenic and tumour suppressor roles of p63 and p73 in cancer: a review by cancer site.
    Orzol P; Holcakova J; Nekulova M; Nenutil R; Vojtesek B; Coates PJ
    Histol Histopathol; 2015 May; 30(5):503-21. PubMed ID: 25510918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One, two, three--p53, p63, p73 and chemosensitivity.
    Müller M; Schleithoff ES; Stremmel W; Melino G; Krammer PH; Schilling T
    Drug Resist Updat; 2006 Dec; 9(6):288-306. PubMed ID: 17287142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p63 and p73 isoform expression in non-small cell lung cancer and corresponding morphological normal lung tissue.
    Lo Iacono M; Monica V; Saviozzi S; Ceppi P; Bracco E; Papotti M; Scagliotti GV
    J Thorac Oncol; 2011 Mar; 6(3):473-81. PubMed ID: 21289519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TP53 family members and human cancers.
    Bénard J; Douc-Rasy S; Ahomadegbe JC
    Hum Mutat; 2003 Mar; 21(3):182-91. PubMed ID: 12619104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p63 and p73 in human cancer: defining the network.
    Deyoung MP; Ellisen LW
    Oncogene; 2007 Aug; 26(36):5169-83. PubMed ID: 17334395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p63 and p73: roles in development and tumor formation.
    Moll UM; Slade N
    Mol Cancer Res; 2004 Jul; 2(7):371-86. PubMed ID: 15280445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of p63 and p73 expression.
    Waltermann A; Kartasheva NN; Dobbelstein M
    Oncogene; 2003 Aug; 22(36):5686-93. PubMed ID: 12944917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of p63 and p73 in human cancers.
    Inoue K; Fry EA
    Subcell Biochem; 2014; 85():17-40. PubMed ID: 25201187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of specific p63 and p63-N-terminal isoform antibodies and their application for immunohistochemistry.
    Nekulova M; Holcakova J; Nenutil R; Stratmann R; Bouchalova P; Müller P; Mouková L; Coates PJ; Vojtesek B
    Virchows Arch; 2013 Sep; 463(3):415-25. PubMed ID: 23887585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p73, a sophisticated p53 family member in the cancer world.
    Ozaki T; Nakagawara A
    Cancer Sci; 2005 Nov; 96(11):729-37. PubMed ID: 16271066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of p53 family members p73 and p63 in human hematological malignancies.
    Alexandrova EM; Moll UM
    Leuk Lymphoma; 2012 Nov; 53(11):2116-29. PubMed ID: 22497596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of DeltaN isoform and polyadenylation site choice variants in molluscan p63/p73-like homologues.
    Muttray AF; Cox RL; Reinisch CL; Baldwin SA
    Mar Biotechnol (NY); 2007; 9(2):217-30. PubMed ID: 17242983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis.
    Choi HR; Batsakis JG; Zhan F; Sturgis E; Luna MA; El-Naggar AK
    Hum Pathol; 2002 Feb; 33(2):158-64. PubMed ID: 11957139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the p53 homologues p63 and p73 in multiple simultaneous gastric cancer.
    Tannapfel A; Schmelzer S; Benicke M; Klimpfinger M; Kohlhaw K; Mössner J; Engeland K; Wittekind C
    J Pathol; 2001 Sep; 195(2):163-70. PubMed ID: 11592094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.
    Murray-Zmijewski F; Lane DP; Bourdon JC
    Cell Death Differ; 2006 Jun; 13(6):962-72. PubMed ID: 16601753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P73 functionally replaces p53 in Adriamycin-treated, p53-deficient breast cancer cells.
    Vayssade M; Haddada H; Faridoni-Laurens L; Tourpin S; Valent A; Bénard J; Ahomadegbe JC
    Int J Cancer; 2005 Oct; 116(6):860-9. PubMed ID: 15849742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The presence of an intronic deletion in p73 and high levels of ZEB1 alter the TAp73/DeltaTAp73 ratio in colorectal carcinomas.
    Domínguez G; Peña C; Silva J; García JM; García V; Rodríguez R; Cantos B; Citores MJ; España P; Bonilla F
    J Pathol; 2006 Dec; 210(4):390-7. PubMed ID: 17029218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck.
    Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
    Int J Cancer; 2002 May; 99(1):22-8. PubMed ID: 11948487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of p63 and p73 in ameloblastomas.
    Kumamoto H; Ohki K; Ooya K
    J Oral Pathol Med; 2005 Apr; 34(4):220-6. PubMed ID: 15752257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The jury is in: p73 is a tumor suppressor after all.
    Rosenbluth JM; Pietenpol JA
    Genes Dev; 2008 Oct; 22(19):2591-5. PubMed ID: 18832062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.